MedTrace Logo

Pre-meal High-performance Inulin Supplementation in Healthy Non-diabetic Subjects

NCT04994353 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2021-08-06

No results posted yet for this study

Summary

In a double-blind, repeated single-arm trial, 8 healthy adults consumed 20 grams of formula that contain 60.2% inulin (w/w) dissolved in 100 ml of water. Blood glucose was measured in fasted participants and at, 30, 60, 90, and 120 minutes after starting to eat a prepared meal (470 Kcal). As supplementation controls, the investigators used the vehicle-glucose, dextrose, isomaltooligosaccharides (IMO), or the combination of IMO and Inulin solution 20% (w/v).

Conditions

  • Diet, Healthy

Interventions

DIETARY_SUPPLEMENT

No supplementation

1st Week: No supplementation

DIETARY_SUPPLEMENT

High Performance (HP) Inulin

2nd Week: Subjects consumed 20% v/v HP Inulin. Ingredients: 20 gram HP-Inulin diluted with 100 ml distilled water.

DIETARY_SUPPLEMENT

Isomalto-oligosaccharide (IMO)

3rd Week: Subjects consumed 20% v/v Isomalto-oligosaccharide (IMO). Ingredients: 20 gram IMO diluted with 100 ml distilled water.

DIETARY_SUPPLEMENT

Combination HP-Inulin and IMO

4th Week: Subjects consumed20% v/v combination of HP-Inulin and Isomalto-oligosaccharide (IMO). Ingredients: 20 gram IMO-HP Inulin "Mix" diluted with 100 ml distilled water.

DIETARY_SUPPLEMENT

Dextrose solution

5th Week:Subjects consumed20% v/v Dextrose solution. Ingredients: 20 gram Dextrose powder diluted with 100 ml distilled water.

DIETARY_SUPPLEMENT

Glucose solution

6th Week:Subjects consumed 20% v/v Glucose solution. Ingredients: 20 gram glucose diluted with 100 ml distilled water.

Sponsors & Collaborators

  • Universitas Katolik Widya Mandala Surabaya

    lead OTHER

Principal Investigators

  • Hendy Wijaya, MD.M.Biomed. · Faculty of Pharmacy, Universitas Katolik Widya Mandala Surabaya

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-12-14
Primary Completion
2021-01-19
Completion
2021-01-19

Countries

  • Indonesia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04994353 on ClinicalTrials.gov